Quick Answer
Singapore offers tech startups up to 400% R&D tax deductions, an IP Box regime taxing qualifying IP income at 5-10%, direct startup grants, and no capital gains tax. The US offers a larger venture ecosystem and restored immediate R&D expensing for domestic research, but its R&D credit is harder to claim, grants are less accessible to foreign founders, and foreign R&D is still amortised over 15 years. Savvy Platform helps tech founders incorporate in Singapore through SavvyStart, with a local nominee director, company secretary and compliance support included.
Why Tech Startups Compare Singapore and the US
Tech startups are R&D-intensive. The jurisdiction they incorporate in determines how much of their R&D spend they recover through tax incentives, how their IP is protected and taxed, and what government funding they can access.
For non-US founders building SaaS, deep tech, biotech or AI companies, Singapore and the US are the two most common choices. Both offer strong innovation ecosystems, but the incentive structures differ significantly.
R&D Tax Incentives
This is the single biggest financial differentiator for tech startups.
Singapore
Singapore's Enterprise Innovation Scheme (EIS) offers up to 400% tax deduction on qualifying R&D expenditure. This means S$100,000 spent on qualifying R&D reduces taxable income by S$400,000.
|
R&D incentive |
Detail |
|
EIS enhanced deduction |
Up to 400% on the first S$400,000 of qualifying R&D |
|
AI-specific deduction (YA 2027-2028) |
400% on qualifying AI expenditure, capped at S$50,000 |
|
Cash payout option |
20% of qualifying expenditure, up to S$20,000/year (for companies that prefer cash) |
|
IP registration deduction |
Up to 400% on qualifying IP registration costs |
|
R&D conducted in Singapore |
Qualifies for enhanced deductions |
|
R&D conducted overseas |
Standard deduction (100%) |
A Singapore tech startup spending S$200,000 on qualifying domestic R&D can reduce its taxable income by S$800,000 under EIS. Combined with SUTE exemptions in the first three years, many tech startups pay effectively zero corporate tax while in their R&D phase.
United States
The US restored immediate expensing of domestic R&D under the One Big Beautiful Bill Act (signed July 4, 2025), reversing the 2022 requirement to capitalise and amortise over 5 years.
|
R&D incentive |
Detail |
|
Section 174 (domestic) |
Immediate expensing restored for tax years after Dec 31, 2024 |
|
Section 174 (foreign) |
Still amortised over 15 years |
|
Section 41 R&D tax credit |
Credit against tax liability, complex qualification requirements |
|
Payroll tax offset |
Startups can apply up to $250,000/year of R&D credit against payroll taxes |
|
SBIR/STTR grant-funded R&D |
Cannot be included in R&D tax credit calculation (considered "funded research") |
|
Documentation requirements |
Extensive, frequently audited by IRS |
The critical difference for non-US founders
If your R&D team is outside the United States, the 15-year amortisation for foreign R&D still applies even after the 2025 fix. A non-US founder with a Delaware C-Corp and a development team in India, Vietnam or Europe must spread those R&D costs over 15 years, dramatically reducing their near-term tax benefit.
Singapore has no equivalent restriction. R&D conducted in Singapore qualifies for up to 400% deduction. R&D conducted overseas qualifies for 100% deduction in the year incurred.
|
Scenario |
Singapore |
US (Delaware C-Corp) |
|
$200K domestic R&D |
Up to $800K deduction (400% EIS) |
$200K immediate expensing (restored 2025) |
|
$200K foreign R&D |
$200K deduction (100%, year incurred) |
$13,333/year over 15 years |
|
R&D tax credit |
N/A (deduction-based system) |
Available but complex, IRS frequently contests |
|
Effective benefit for startup |
Near-zero tax in R&D phase |
Depends on credit qualification and domestic vs foreign split |
IP Protection and Taxation
IP protection
Both jurisdictions offer strong IP protection through mature patent, trademark and copyright systems.
|
IP factor |
Singapore |
United States |
|
Patent office |
IPOS |
USPTO |
|
Legal system |
English common law |
Common law (federal + state) |
|
Patent enforcement |
Efficient, lower litigation cost |
Strong but extremely expensive |
|
Trade secret protection |
Common law + contract |
Defend Trade Secrets Act (federal) |
|
Average patent litigation cost |
Significantly lower than US |
US$3-5M+ for full patent trial |
The US has the stronger patent enforcement system in absolute terms, but at a cost that most startups cannot afford. Singapore offers effective IP protection at a fraction of the US litigation cost.
IP taxation
This is where Singapore has a clear structural advantage.
|
IP tax factor |
Singapore |
United States |
|
IP Box regime |
IDI: 5%, 10% or 15% tax on qualifying IP income |
No equivalent |
|
Capital gains on IP sale |
None |
Taxable at corporate rate (21%) |
|
IP registration deduction |
Up to 400% (EIS) |
Standard deduction |
|
IP acquisition deduction |
Up to 400% on first S$400,000 (EIS) |
Amortised over 15 years (Section 197) |
Singapore's Intellectual Property Development Incentive (IDI) allows companies to pay as little as 5% tax on income from patents, software and other qualifying IP. The US has no equivalent IP Box regime. A SaaS company generating $1M in revenue from proprietary software pays 5% in Singapore under IDI versus 21% federal tax in the US (before state taxes).
Startup Grants and Government Funding
Singapore
Singapore's government actively funds startups through direct grants and co-investment programmes.
|
Programme |
What it provides |
Eligibility |
|
Startup SG Founder |
Up to S$50,000 co-funding (matching) |
Singapore-incorporated startups, including foreign-founded |
|
Startup SG Tech (POC) |
Up to S$250,000 for proof of concept |
Technology-focused startups |
|
Startup SG Tech (POV) |
Up to S$500,000 for proof of value |
Technology startups with POC completed |
|
Enterprise Development Grant (EDG) |
Up to 50% of qualifying project costs |
Singapore-registered companies |
|
Market Readiness Assistance (MRA) |
Up to S$100,000 for internationalisation |
Singapore-registered companies |
|
DTDi |
200% tax deduction on overseas expansion costs |
Singapore tax resident companies |
These programmes are accessible to foreign-founded companies incorporated in Singapore. Processing times are weeks to months, not years.
United States
|
Programme |
What it provides |
Accessibility for non-US founders |
|
SBIR Phase I |
Up to ~$275,000 |
Difficult. Company must be 51%+ US-owned and primarily US-operated. |
|
SBIR Phase II |
Up to ~$1.75M |
Same ownership and operation requirements |
|
STTR Phase I |
Up to ~$275,000 |
Requires partnership with a US research institution |
|
State-level grants |
Varies widely |
Varies by state, often requires in-state presence |
|
SBA loans |
Variable |
Requires a US presence and a credit history |
The US SBIR/STTR programmes are the largest government innovation funding programmes in the world. However, they require 51%+ US ownership and principal operations in the US, making them effectively inaccessible to non-US founders with a Delaware shell entity.
Additionally, the current administration's FY2026 budget proposes significant cuts to NIH (37%), NSF (50%+) and other agencies that operate SBIR/STTR programmes. The future funding landscape is uncertain.
|
Comparison |
Singapore |
United States |
|
Accessible to foreign founders |
Yes |
Largely no (SBIR/STTR require US ownership) |
|
Grant processing speed |
Weeks to months |
Months to years |
|
Funding certainty |
Stable, multi-year budget commitments |
Subject to annual budget negotiations and agency cuts |
|
Grant scope |
R&D, POC, internationalisation, market expansion |
Primarily R&D (SBIR/STTR) |
|
Grant interaction with tax incentives |
Grants do not reduce R&D deduction eligibility |
SBIR-funded R&D cannot be claimed for R&D tax credit |
Founder Residency and Talent Access
|
Factor |
Singapore |
United States |
|
Founder visa |
Employment Pass (S$5,600/month) or EntrePass |
No dedicated founder visa (E-2, L-1, O-1, EB-5) |
|
Tech talent visa |
Tech.Pass (for established tech entrepreneurs) |
H-1B (lottery-based, capped) |
|
Speed to residency |
EP in weeks, PR path in 6-12 months |
Visa processing months to years, Green Card years |
|
Talent pool |
Strong in fintech, AI, biotech |
Largest global talent pool, but visa limitations for hiring |
Singapore offers a more predictable path for founders to establish residency and hire international talent. The US has a deeper talent pool but its visa system (H-1B lottery, visa backlogs) creates hiring friction.
When the US Is the Better Choice for Tech Startups
The US is genuinely stronger when:
- The startup targets primarily US enterprise customers
- The founding team is US-based and benefits from QSBS
- The company qualifies for SBIR/STTR funding (51%+ US-owned)
- Deep integration with US-specific platforms or partners is required
- A US IPO or NASDAQ listing is the intended exit
When Singapore Is the Better Choice
Singapore is the stronger choice when:
- The R&D team is outside the US (avoiding 15-year foreign R&D amortisation)
- The company generates revenue from proprietary IP (IDI: 5-10% tax)
- The founder wants accessible government grants without US ownership requirements
- The startup serves global or Asia-Pacific markets
- The founder wants a clear residency path
- The founder wants lower litigation cost for IP enforcement
How Savvy Platform Helps Tech Founders
Savvy Platform provides incorporation designed for R&D-intensive and IP-heavy startups.
Savvy Platform offers:
- Company incorporation through SavvyStart
- Nominee director during setup
- Company secretary and registered address
- Bank account setup support
- Employment Pass assistance
- Ongoing compliance and filing management
For tech founders who want to maximise R&D incentives and protect IP in a low-tax, common law jurisdiction, Savvy Platform handles the corporate setup so they can focus on building.
Conclusion
Singapore and the US both support tech startups, but through fundamentally different incentive structures. Singapore offers higher R&D deductions, an IP Box regime, accessible grants for foreign founders, and no capital gains tax. The US offers a larger market, deeper talent pool and restored domestic R&D expensing, but foreign R&D is still penalised, grants require US ownership, and IP income is taxed at the full corporate rate. For non-US tech founders, Singapore is the more efficient base. Savvy Platform makes the setup fast and compliant.
FAQ
What is Singapore's R&D tax deduction rate?
Up to 400% under the Enterprise Innovation Scheme (EIS) on the first S$400,000 of qualifying R&D expenditure. A new 400% AI-specific deduction is also available for YA 2027-2028.
Has the US fixed the Section 174 R&D amortisation issue?
Partially. The One Big Beautiful Bill Act (July 2025) restored immediate expensing for domestic R&D. Foreign R&D expenses must still be amortised over 15 years.
Can non-US founders access SBIR/STTR grants?
Effectively no. SBIR/STTR require the company to be 51%+ US-owned and principally operated in the US. A Delaware entity owned by a foreign founder does not qualify.
What is Singapore's IP Box regime?
The Intellectual Property Development Incentive (IDI) allows qualifying companies to pay 5%, 10% or 15% tax on income from patents, software and other IP, instead of the standard 17%.
Is patent litigation cheaper in Singapore?
Yes, significantly. US patent litigation can cost US$3-5M+ for a full trial. Singapore IP enforcement is considerably less expensive while still providing effective protection.
Can a Singapore startup access both EIS and startup grants?
Yes. EIS tax deductions and government grants (Startup SG, EDG, MRA) are separate programmes that can be used together. However, the same expenditure cannot be claimed under multiple tax schemes.
Does the US R&D tax credit work for startups?
The US R&D credit (Section 41) is available but complex to claim and frequently contested by the IRS. Startups can apply up to $250,000/year against payroll taxes, which is useful for pre-revenue companies.
Does Savvy Platform support IP-heavy startups?
Yes. Savvy Platform incorporates companies that plan to hold and monetise IP in Singapore, taking advantage of the IDI regime and EIS deductions as part of their corporate structure.